Acetylation modification and chronic obstructive pulmonary disease

doi:10.16352/j.issn.1001-6325.2025.04.0536

Abstract

Abstract: The main features of chronic obstructive pulmonary disease include chronic airway inflammation, persistent airflow limitation, progressive dyspnea, and impaired lung function. Acetylation is one of the most common post-translational modifications of proteins, which plays an important role in the pathogenesis of chronic obstructive pulmonary disease, such as oxidative stress, inflammatory reaction, and airway remodeling, by regulating gene expression, cell signaling, and protein function. Therefore, exploring the regulatory mechanism of acetylating modification in chronic obstructive pulmonary disease can not only deeply understand the pathophysiological mechanism of the disease, but also provide a theoretical basis for the development of new treatment strategies.

Key words: acetylation, chronic obstructive pulmonary disease, inflammatory reaction, oxidative stress

CLC Number:

WANG Pei, BIAN Tao, WU Yan. Acetylation modification and chronic obstructive pulmonary disease[J]. Basic & Clinical Medicine, 2025, 45(4): 536-541.

References

[1] Chen S, Kuhn M, Prettner K, et al. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study[J]. Lancet Glob Health, 2023, 11: e1183-e1193.
[2] Ahmad S, Manzoor S, Siddiqui S, et al. Epigenetic underpinnings of inflammation: connecting the dots between pulmonary diseases, lung cancer and COVID-19[J]. Semin Cancer Biol, 2022,83:384-398.
[3] Chen M, Chen Z, Huang D, et al. Myricetin inhibits TNF-α-induced inflammation in A549 cells via the SIRT1/NF-κB pathway[J]. Pulm Pharmacol Ther, 2020, 65:102000. doi: 10.1016/j.pupt.2021.102000.
[4] Lee K, Woo J, Kim JY, et al. Cigarette smoke extract-induced downregulation of p300 is responsible for the impaired inflammatory cytokine response of macrophages[J]. Cell Signal, 2021, 85:110050. doi: 10.1016/j.cellsig.2021.110050.
[5] Hodge G, Tran HB, Reynolds PN, et al. Lymphocyte senescence in COPD is associated with decreased sirtuin 1 expression in steroid resistant pro-inflammatory lymphocytes[J]. Ther Adv Respir Dis, 2020,14:1753466620905280. doi: 10.1177/1753466620905280.
[6] Zhang J, Xu Z, Kong L, et al. miRNA-486-5p promotes COPD progression by targeting HAT1 to regulate the TLR4-triggered inflammatory response of alveolar macrophages[J]. Int J Chron Obstruct Pulmon Dis, 2020,15:2991-3001.
[7] Guo Y, Liu Q, Zheng Z, et al. Genetic association of inflammatory marker GlycA with lung function and respiratory diseases[J]. Nat Commun, 2024,15:3751. doi: 10.1038/s41467-024-47845-w.
[8] Li C, Chen F, Lin L, et al. CSE triggers ferroptosis via SIRT4-mediated GNPAT deacetylation in the pathogenesis of COPD[J]. Respir Res, 2023,24:301. doi: 10.1186/s12931-023-02613-0.
[9] Montero Magalló P, Roger Laparra I, Estornut Navarro C, et al. Influence of dose and exposition time in the effectiveness of N-Acetyl-L-cysteine treatment in A549 human epithelial cells[J]. Heliyon, 2023, 9:e15613. doi: 10.1016/j.heliyon.2023.e15613.
[10] Son ES, Park J, Kim YJ, et al. Effects of antioxidants on oxidative stress and inflammatory responses of human bronchial epithelial cells exposed to particulate matter and cigarette smoke extract[J]. Toxicol In Vitro, 2020, 67:104883. doi: 10.1016/j.tiv.2020.104883.
[11] Lee K, Woo J, Kim J, et al. YPL-001 shows various beneficial effects against cigarette smoke extract-induced emphysema formation: anti-inflammatory, anti-oxidative, and anti-apoptotic effects[J]. Antioxidants (Basel), 2022 ,12:15. doi: 10.3390/antiox12010015.
[12] Hung JY, Chiang SR, Tsai MJ, et al. LIGHT is a crucial mediator of airway remodeling[J]. J Cell Physiol, 2015, 230:1042-1053.
[13] Zeng M, Zhang X, Xing W, et al. Cigarette smoke extract mediates cell premature senescence in chronic obstructive pulmonary disease patients by up-regulating USP7 to activate p300-p53/p21 pathway[J]. Toxicol Lett, 2022, 359: 31-45.
[14] Wu H, Ma H, Wang L, et al. Regulation of lung epithelial cell senescence in smoking-induced COPD/emphysema by microR-125a-5p via Sp1 mediation of SIRT1/HIF-1α[J]. Int J Biol Sci, 2022,18:661-674.
[15] Tao L, Lu X, Fu Z, et al. Tong Sai granule improves AECOPD via regulation of MAPK-SIRT1-NF-κB pathway and cellular senescence alleviation[J]. J Ethnopharmacol, 2023,314:116622. doi: 10.1016/j.jep.2023.116622.
[16] Zhang X, Li W, Zhang J, et al. Roles of sirtuin family members in chronic obstructive pulmonary disease[J]. Respir Res, 2022,23:66. doi: 10.1186/s12931-022-01986-y.
[17] Barnes PJ. Small airway fibrosis in COPD[J]. Int J Biochem Cell Biol, 2019,116:105598. doi: 10.1016/j.biocel.2019.105598.
[18] Wu X, Ciminieri C, Bos I S T, et al. Diesel exhaust particles distort lung epithelial progenitors and their fibroblast niche[J]. Environ Pollut, 2022, 305:119292. doi: 10.1016/j.envpol.2022.119292.
[19] Zheng G, Li C, Chen X, et al. HDAC9 inhibition reduces skeletal muscle atrophy and enhances regeneration in mice with cigarette smoke-induced COPD[J]. Biochim Biophys Acta Mol Basis Dis, 2024,1870:167023. doi:10.1016/j.bbadis.2024.167023.
[20] Zwinderman MR, de Weerd S, Dekker FJ. Targeting HDAC complexes in asthma and COPD[J]. Epigenomes, 2019, 3:19. doi: 10.3390/epigenomes3030019.
[21] Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol, 2013, 131: 636-645.
[22] Leus NG, Zwinderman MR, Dekker FJ. Histone deacetylase 3 (HDAC 3) as emerging drug target in NF-κB-mediated inflammation[J]. Curr Opin Chem Biol, 2016, 33: 160-168.
[23] Cazzola M, Page CP, Wedzicha JA, et al. Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD[J]. Respir Res, 2023, 24:194. doi: 10.1186/s12931-023-02500-8.
[24] Papi A, Zheng J, Criner GJ, et al. Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: a post-hoc analysis of the PANTHEON study[J]. Respir Med, 2019, 147: 37-43.
[25] Lewis P, Sheehan D, Soares R, et al. Chronic sustained hypoxia-induced redox remodeling causes contractile dysfunction in mouse sternohyoid muscle[J]. Front Physiol, 2015, 6:122. doi: 10.3389/fphys.2015.00122.